The global Semaglutide market is estimated to be valued at USD 2.17 billion in 2021 and is expected to exhibit a CAGR of 8.71% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes. It is an injectable medication that helps improve blood sugar control by increasing insulin secretion and reducing ... Read more

The global Semaglutide market is estimated to be valued at US$ 2.17 Billion in 2022 and is expected to exhibit a CAGR of 8.71% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Semaglutide is an injectable glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes and obesity. It helps in regulating blood sugar levels and promotes ... Read more